© Howard Kingsnorth
– Olivier Goy has been the founded of the about fintech October.
Olivier Goy, reached since 2020 by Charcot's disease, a progressive neuromuscular pathology which notably impacts walking, speech, swallowing and breathing, undertake and help research to move forward. Questioned by BFMTV, he confides that even if he had “This reflex to think that everything was going to stop”he understood that he could “Still undertake differently”in particular by reinventing his way of working.
Today he chairs the Fintech Octuber Management Board, of which he is the founder. He is also the vice-president of the France Fintech association and the Brain Institute's ambassador, reports the news channel continuously. Olivier Goy now wishes to contribute to the improvement of “The quality of life of the sick”. He has already managed to harvest more than 2.5 million euros For the Brain Institute and has just launched a philanthropic fund to finance research on Charcot's disease.
-Auto-entrepreneur and employee, why combine the two statutes?
Millions of euros in perspective donations
This fund will be invested in private debt funds and the generated return will be donated. “In cruising pace, a fund of 20 million euros has the target target to generate one million euros in annual income in a lasting way for research “he specifies to our colleagues. Donations will allow researchers to study pathology to develop new projects that mostly cost several hundred thousand euros.
Charcot disease is an incurable disease that affects more and more people in France and whose number of cases doubled in 20 years. It leads to muscle atrophy and progressive paralysis of patients.
